The purpose of the study is to understand the role of interleukin-6 during physical activity in patients with type 2 diabetes.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Enrollment
56
University Hospital Zurich
Zurich, Switzerland
Glucagon like peptide- 1 (GLP-1)
Time frame: Change in GLP-1 secretion compared to baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.